201 related articles for article (PubMed ID: 27826370)
1. Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs.
Yilmaz C; Sarisozen C; Torchilin V; Busnaina A
Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):157-162. PubMed ID: 27826370
[TBL] [Abstract][Full Text] [Related]
2. Supersaturated polymeric micelles for oral cyclosporine A delivery.
Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Predicting the complex phase behavior of self-assembling drug delivery nanoparticles.
Le TC; Mulet X; Burden FR; Winkler DA
Mol Pharm; 2013 Apr; 10(4):1368-77. PubMed ID: 23464802
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.
Lu Y; Park K
Int J Pharm; 2013 Aug; 453(1):198-214. PubMed ID: 22944304
[TBL] [Abstract][Full Text] [Related]
6. Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy.
Sun H; Meng F; Cheng R; Deng C; Zhong Z
Expert Opin Drug Deliv; 2013 Aug; 10(8):1109-22. PubMed ID: 23517599
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities.
Bisht S; Feldmann G; Koorstra JB; Mullendore M; Alvarez H; Karikari C; Rudek MA; Lee CK; Maitra A; Maitra A
Mol Cancer Ther; 2008 Dec; 7(12):3878-88. PubMed ID: 19074860
[TBL] [Abstract][Full Text] [Related]
8. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.
Danhier F; Ucakar B; Vanderhaegen ML; Brewster ME; Arien T; Préat V
Eur J Pharm Biopharm; 2014 Sep; 88(1):252-60. PubMed ID: 24859391
[TBL] [Abstract][Full Text] [Related]
10. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
11. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
Merisko-Liversidge E; Liversidge GG
Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
[TBL] [Abstract][Full Text] [Related]
12. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
13. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs.
Kim JY; Kim S; Pinal R; Park K
J Control Release; 2011 May; 152(1):13-20. PubMed ID: 21352878
[TBL] [Abstract][Full Text] [Related]
14. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
15. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.
Lee SC; Huh KM; Lee J; Cho YW; Galinsky RE; Park K
Biomacromolecules; 2007 Jan; 8(1):202-8. PubMed ID: 17206808
[TBL] [Abstract][Full Text] [Related]
16. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
Lukyanov AN; Torchilin VP
Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
[TBL] [Abstract][Full Text] [Related]
17. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: formulation, characterization, and in vivo pharmacokinetics.
Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
Eur J Pharm Biopharm; 2013 Aug; 84(3):487-96. PubMed ID: 23403015
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of anticancer drugs III: formulation using drug delivery systems.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):99-104. PubMed ID: 22981667
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
Joshi G; Kumar A; Sawant K
Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
[TBL] [Abstract][Full Text] [Related]
20. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
